Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

被引:36
作者
Axelsson, J.
Qureshi, A. R.
Divino-Filho, J. C.
Barany, P.
Heimburger, O.
Lindholm, B.
Stenvinkel, P.
机构
[1] Karolinska Univ Hosp, Dept Renal Med, Karolinska Inst, S-14186 Stockholm, Sweden
[2] Karolinska Univ Hosp, Div Baxter Novum, Karolinska Inst, Dept Clin Sci Intervent & Technol, S-14186 Stockholm, Sweden
关键词
IGF; chronic renal failure; end-stage renal disease; malnutrition; inflammation;
D O I
10.1038/sj.ejcn.1602373
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: Malnutrition is common in end-stage renal disease ( ESRD) and affects both morbidity and mortality. The growth hormone-dependent insulin-like growth factor ( IGF)-I may be a good marker of malnutrition because of its short half-life. In the present study, we investigate the influence of decreasing residual renal function as well as of chronic inflammation on the IGF system to assess its usefulness in this patient group. Patients and methods: Cross-sectional analysis of 220 ESRD patients ( 140 males) with a mean age of 5271 years. Biochemical analyses of insulin, IGF-I, IGFBP-1, IGFBP-3, IL-6, high sensitivity ( hs)-CRP and other routine markers. Malnutrition status was recorded using subjective global assessment ( SGA), body mass index, estimated protein intake from nitrogen appearance ( nPNA), handgrip strength ( HGS) and insulin resistance ( HOMA-IR). Dual energy X-ray absorptiometry was used to assess body composition. Results: Both IGF-I and IGFBP-1 showed significant and opposite correlations with most markers of nutritional status, including SGA ( rho = 0.29 and 0.27; P < 0.001), nPNA ( rho = 0.18 and -0.22; P < 0.05), S- creatinine ( rho = 0.19 and -0.19; P < 0.01) and HGS ( rho = 0.21 and -0.25; P < 0.01). IFG-I was strongly correlated with IGFBP-3 ( rho = 0.62; P < 0.001) and inversely correlated with IGFBP-1 ( rho = 0.44; P < 0.001). Both IGF-I and IGFBP-3, but not IGFBP-1, were significantly correlated with age ( rho = -0.25 for IGF-I and -0.35 for IGFBP-3; P < 0.001) and hsCRP ( rho = -0.21 and -0.32; P < 0.01). In multivariate analysis, SGA and s-albumin were independent predictors of both IGF-I and IGFBP-1. Conclusion: Both IGF-I and IGFBP-1 appear to correlate well with markers of protein-energy malnutrition and sarcopenia. However, IGF- I is also influenced by age, whereas IGFBP-1 is influenced by glucose metabolism. IGFBP-3 does not correlate with nutritional status in ESRD, perhaps because of a strong association with inflammation.
引用
收藏
页码:718 / 726
页数:9
相关论文
共 48 条
  • [1] Truncal fat mass as a contributor to inflammation in end-stage renal disease
    Axelsson, J
    Qureshi, AR
    Suliman, ME
    Honda, H
    Pecoits-Filho, R
    Heimbürger, O
    Lindholm, B
    Cederholm, T
    Stenvinkel, P
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (05) : 1222 - 1229
  • [2] BARBIERI M, 2003, AM J PHYSIOL-ENDOC M, V284, pE841
  • [3] BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329
  • [4] Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study
    Boonen, S
    Lysens, R
    Verbeke, G
    Joosten, E
    Dejaeger, E
    Pelemans, W
    Flamaing, J
    Bouillon, R
    [J]. AGE AND AGEING, 1998, 27 (04) : 449 - 454
  • [5] Role of IGF-I in muscular atrophy of aging
    Borst, SE
    Lowenthal, DT
    [J]. ENDOCRINE, 1997, 7 (01) : 61 - 63
  • [6] Brisse H, 1994, B ASS INFORMATIQUE, V1, P1
  • [7] Association of IGF-I levels with muscle strength and mobility in older women
    Cappola, AR
    Bandeen-Roche, K
    Wand, GS
    Volpato, S
    Fried, LP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) : 4139 - 4146
  • [8] Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5
  • [9] Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection
    de Martino, M
    Galli, L
    Chiarelli, F
    Verrotti, A
    Rossi, ME
    Bindi, G
    Galluzzi, F
    Salti, R
    Vierucci, A
    [J]. CLINICAL IMMUNOLOGY, 2000, 94 (03) : 212 - 218
  • [10] Structural biology of insulin and IGF1 receptors: Implications for drug design
    De Meyts, P
    Whittaker, J
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) : 769 - 783